Home / Health / NHS England & Wales to Offer Teplizumab for Type 1 Diabetes
NHS England & Wales to Offer Teplizumab for Type 1 Diabetes
28 Jun
Summary
- Teplizumab will be available on the NHS in England and Wales.
- The drug does not cure Type 1 diabetes but delays its onset.
- Onset of Type 1 diabetes can be delayed for up to three years.
Teplizumab is now confirmed to be accessible via the NHS across England and Wales. This development marks a significant step in managing Type 1 diabetes, a chronic autoimmune condition where the pancreas is unable to produce insulin.
This new treatment does not offer a cure for Type 1 diabetes. However, it has demonstrated efficacy in delaying the onset of the disease. Initial findings suggest that the drug can postpone the development of Type 1 diabetes for as long as three years.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
